Microbix renegotiates Chinese vax plant deal; Sanofi Pasteur typhoid vax receives prequalification from WHO;

Vaccine Research

Researchers have found that an accelerated hepatitis B vaccination schedule was effective and well tolerated in at-risk pregnant women. The three shots were give in 12 weeks, instead of the usual six months. Story

Vaccine Market

Microbix Biosystems and Hunan Biopharmaceutical are renegotiating key terms in their joint venture agreement to create Asia's largest flu vaccine production facility. The talks come after Microbix closed Phase I financing for its subsidiary Crucible and Hunan expressed interest in altering portions of the agreement. Microbix release

Sanofi Pasteur has received a prequalification from the World Health Organization for its polysaccharide typhoid vaccine, Typhim Vi. It's the first typhoid vaccine to receive the status. Item

Annapolis, MD-based PharmAthene reached a technical milestone in its recombinant protective antigen anthrax vaccine program by finishing the initial technology transfer of its SparVax manufacturing process. PharmAthene release

And Finally... A study found that Amish parents who refuse to vaccinate their children are driven by the same reasons as non-Amish parents, rather than their religious beliefs. In Holmes County, OH, 49 unvaccinated families responded to a survey and stated they didn't feel vaccines were worth the risks, rather than a matter of access to the vaccines. Report

Suggested Articles

The scientific community has again been caught off guard and industry officials are talking about implementing better preventive measures.

Sanofi didn't hesitate to enter Zika vaccine R&D, and despite the associated scandal, the company is again jumping into emerging disease vaccine R…

NIH and Moderna will need a coronavirus vaccine manufacturer, and and no major pharmaceutical company has stepped up.